by James Radke, PhD | Apr 11, 2025
A recent study evaluated outcomes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) patients treated with R-GemOx. DLBCL is a form of non-Hodgkin lymphoma. Lymphomas occur when cells of the immune system, B lymphocytes, grow and multiply uncontrollably....
by James Radke, PhD | May 7, 2024
Alessio Di Fonzo, MD, PhD, neurologist at the University of Milan, discusses research looking into the connection between Gaucher disease and Parkinson’s. Gaucher Disease Gaucher disease refers to a group of inherited metabolic diseases in which harmful...
by James Radke, PhD | Apr 2, 2024
Sarah Cortell Vandersypen, Executive Director of the United MSD Foundation, discusses the organization’s work with multiple sulfatase deficiency. The United MSD Foundation is an international patient advocacy group focused on providing support for...
by James Radke, PhD | Mar 26, 2024
Dean Suhr, President and Co-Founder of MLD Foundation, discusses current and emerging treatment options in metachromatic leukodystrophy (MLD). MLD is a genetic lysosomal disorder characterized by the toxic buildup of lipids and other storage materials...
by Madaline Spencer and James Radke, PhD | Jul 19, 2023
Karen Ball, founder of the Surge-Weber Foundation discusses Sturge-Weber Syndrome, a rare neurovascular disease. Sturge-Weber syndrome is a rare neurocutaneous disorder that primarily affects the skin and the central nervous system. It is characterized...
